277 related articles for article (PubMed ID: 11418645)
21. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
Sato S; Miller AS; Howard MC; Tedder TF
J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
[TBL] [Abstract][Full Text] [Related]
22. Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex.
Mongini PK; Inman JK
Cell Immunol; 2001 Feb; 207(2):127-40. PubMed ID: 11243702
[TBL] [Abstract][Full Text] [Related]
23. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
[TBL] [Abstract][Full Text] [Related]
24. CD19 can regulate B lymphocyte signal transduction independent of complement activation.
Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Tedder TF
J Immunol; 2001 Sep; 167(6):3190-200. PubMed ID: 11544305
[TBL] [Abstract][Full Text] [Related]
25. Signaling by the CD19/CD21 complex on B cells.
Carter RH; Barrington RA
Curr Dir Autoimmun; 2004; 7():4-32. PubMed ID: 14719373
[TBL] [Abstract][Full Text] [Related]
26. Targeting antigen to CD19 on B cells efficiently activates T cells.
Yan J; Wolff MJ; Unternaehrer J; Mellman I; Mamula MJ
Int Immunol; 2005 Jul; 17(7):869-77. PubMed ID: 15967786
[TBL] [Abstract][Full Text] [Related]
27. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.
Fearon DT; Carroll MC
Annu Rev Immunol; 2000; 18():393-422. PubMed ID: 10837064
[TBL] [Abstract][Full Text] [Related]
28. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2).
Mongini PK; Vilensky MA; Highet PF; Inman JK
J Immunol; 1997 Oct; 159(8):3782-91. PubMed ID: 9378965
[TBL] [Abstract][Full Text] [Related]
29. Modeling the presentation of C3d-coated antigen by B lymphocytes: enhancement by CR1/2-BCR co-ligation is selective for the co-ligating antigen.
Prechl J; Baiu DC; Horváth A; Erdei A
Int Immunol; 2002 Mar; 14(3):241-7. PubMed ID: 11867560
[TBL] [Abstract][Full Text] [Related]
30. Complement's participation in acquired immunity.
Nielsen CH; Leslie RG
J Leukoc Biol; 2002 Aug; 72(2):249-61. PubMed ID: 12149415
[TBL] [Abstract][Full Text] [Related]
31. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
[TBL] [Abstract][Full Text] [Related]
32. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
Bouillie S; Barel M; Frade R
J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
[TBL] [Abstract][Full Text] [Related]
33. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression.
Haas KM; Toapanta FR; Oliver JA; Poe JC; Weis JH; Karp DR; Bower JF; Ross TM; Tedder TF
J Immunol; 2004 May; 172(10):5833-7. PubMed ID: 15128761
[TBL] [Abstract][Full Text] [Related]
34. B-lymphocyte signaling receptors and the control of class-II antigen processing.
Wagle NM; Cheng P; Kim J; Sproul TW; Kausch KD; Pierce SK
Curr Top Microbiol Immunol; 2000; 245(2):101-26. PubMed ID: 10533320
[No Abstract] [Full Text] [Related]
35. CD21 augments antigen presentation in immune individuals.
Boackle SA; Holers VM; Karp DR
Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
[TBL] [Abstract][Full Text] [Related]
36. Prolonged antigen persistence within nonterminal late endocytic compartments of antigen-specific B lymphocytes.
Gondré-Lewis TA; Moquin AE; Drake JR
J Immunol; 2001 Jun; 166(11):6657-64. PubMed ID: 11359820
[TBL] [Abstract][Full Text] [Related]
37. Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathway.
Lyubchenko T; dal Porto J; Cambier JC; Holers VM
J Immunol; 2005 Mar; 174(6):3264-72. PubMed ID: 15749857
[TBL] [Abstract][Full Text] [Related]
38. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand.
Depoil D; Fleire S; Treanor BL; Weber M; Harwood NE; Marchbank KL; Tybulewicz VL; Batista FD
Nat Immunol; 2008 Jan; 9(1):63-72. PubMed ID: 18059271
[TBL] [Abstract][Full Text] [Related]
39. Distinct sequences in the cytoplasmic domain of complement receptor 2 are involved in antigen internalization and presentation.
Barrault DV; Knight AM
J Immunol; 2004 Mar; 172(6):3509-17. PubMed ID: 15004151
[TBL] [Abstract][Full Text] [Related]
40. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes.
Fearon DT
Curr Opin Immunol; 1993 Jun; 5(3):341-8. PubMed ID: 7688513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
